Browse By Cell Line Result Page of OvirusTdb

The total number of records retrieved from this search are 148. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_606AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15Key Laboratory of Zoonosis, Jilin UniversityHuman prostate cancer cell linePC-3M1.0E+5 cells per wellNAMTT assay0.1 MOI70% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_609AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15Key Laboratory of Zoonosis, Jilin UniversityHuman prostate cancer cell linePC-3M1.0E+5 cells per wellNAMTT assay1 MOI40% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_612AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15Key Laboratory of Zoonosis, Jilin UniversityHuman prostate cancer cell linePC-3M1.0E+5 cells per wellNAMTT assay10 MOI18% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_615AdenovirusCRAd-CCL21-IL15DNAAdenoviridaeInsertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cellsYesNoIL-15Key Laboratory of Zoonosis, Jilin UniversityHuman prostate cancer cell linePC-3M1.0E+5 cells per wellNAMTT assay50 MOI10% cancer cell viabilityNoNoNA No responseNANANANA27380620
OV_717Avian influenza A virusH7N3 NS1-77RNAOrthomyxoviridaeMutations were introduced within the IAV NS1 gene to create a truncated protein of 77 aa (NS1-77)YesNoNoNAHuman pancreatic cancer cell lineBxPC-3NANAImmunoassay detection0.001 MOI130% cancer cell death (calculated as relative to mock-infected)NoNoNA No responseNANAUp-regulation of IFN-aplhaNA27417501
OV_721Avian influenza A virusH7N3RNAOrthomyxoviridaeNoneYesNoNoNAHuman pancreatic cancer cell lineBxPC-3NANAImmunoassay detection0.001 MOI148% cancer cell death (calculated as relative to mock-infected)NoNoNA No responseNANAUp-regulation of IFN-aplhaNA27417501
OV_898Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell2% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_899Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell20% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_900Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell50% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_901Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell20% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_902Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell40% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_903Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell80% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_904Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell60% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_905Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell80% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_906Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.01 pfu/cell90% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_907Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell20% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_908Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell30% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_909Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell50% cancer cell killing after 24 hourNoNoNA No responseNANANANA15129429
OV_910Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell50% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_911Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell60% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_912Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell100% cancer cell killing after 48 hourNoNoNA No responseNANANANA15129429
OV_913Herpes simplex virusBaco-1DNAHerpesviridaeNon- fusogenic ligated with EGFP proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell60% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_914Herpes simplex virusSynco-2DNAHerpesviridaeFusogenic membrane ligated with GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell80% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_915Herpes simplex virusSynco-2DDNAHerpesviridaeDouble fusogenic expressing EGFP and GALV.fus proteinYesNoNoATCCProstate cancer cell linePC-3M-Pro45.0E+4 cells per wellNATrypan blue staining0.1 pfu/cell100% cancer cell killing after 72 hoursNoNoNA No responseNANANANA15129429
OV_1261AdenovirusAxdAdb-3DNAAdenoviridaeDouble mutated for E1A and E1B geneYesNoNoATCCProstate cancer cell linePC-33.0E+3 cells per wellMTT assay30 MOISurviving cell number reached to 10000NoNoNA No responseNANANANA18063085
OV_1290AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics0.1 MOI98% cell viability after day 1NoNoNA No responseNANANANA18274558
OV_1291AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics0.1 MOI90% cell viability after day 2NoNoNA No responseNANANANA18274558
OV_1292AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics0.1 MOI100% cell viability after day 3NoNoNA No responseNANANANA18274558
OV_1293AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics0.1 MOI98% cell viability after day 4NoNoNA No responseNANANANA18274558
OV_1294AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics1 MOI98% cell viability after day 1NoNoNA No responseNANANANA18274558
OV_1295AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics1 MOI80% cell viability after day 2NoNoNA No responseNANANANA18274558
OV_1296AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics1 MOI70% cell viability after day 3NoNoNA No responseNANANANA18274558
OV_1297AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics1 MOI60% cell viability after day 4NoNoNA No responseNANANANA18274558
OV_1298AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics10 MOI60% cell viability after day 1NoNoNA No responseNANANANA18274558
OV_1299AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics10 MOI40% cell viability after day 2NoNoNA No responseNANANANA18274558
OV_1300AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics10 MOI30% cell viability afterd ay 3NoNoNA No responseNANANANA18274558
OV_1301AdenovirusOBP-301DNAAdenoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-31000 cells per wellNACell proliferation kit by Roche Diagnostics10 MOI20% cell viability after day 4NoNoNA No responseNANANANA18274558
OV_1408ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (25 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-3NANAMTT assay0.5 MOI70% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_1409ParovirusH-1PVDNAParoviridaeNoneNoVirus strain in combination with norfloxacin (25 microgram/ml)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-3NANAMTT assay1 MOI30% cell survivalNoNoNA No responseNAInduction of apoptosis, activation of caspase 3NANA19301953
OV_2014ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.1 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2015ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay1 MOI30% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2016ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay10 MOI10% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2017ReovirusReovirus T3DRNAReoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay100 MOI100% cell deathNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2026ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (7.5 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.125 MOI80% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2027ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (15 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.25 MOI70% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2028ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (30 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay0.5 MOI60% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2029ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (60 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay1 MOI50% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2030ReovirusReovirus T3DRNAReoviridaeNoneNoVirus strain in combination with Docetaxel (120 nM)NoNAHuman prostate cancer cell linePC-35.0E+3 cells per wellNAMTS assay2 MOI40% cell survivalNoNoNA No responseNAVirus cause increase in apoptosisNANA21645351
OV_2278Vesicular stomatitis viruswild typeRNARhabdoviridaeNoneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay1 MOI60% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2292Vesicular stomatitis virusVSV-Delta-M51-GFPRNARhabdoviridaeDeletion of M51 gene and insertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay1 MOI80% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2306Vesicular stomatitis virusVSV-p1-GFPRNARhabdoviridaeInsertion of P geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay1 MOI70% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2320Vesicular stomatitis virusSev-GFPRNARhabdoviridaeInsertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay1 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2334Vesicular stomatitis virusRSV-GFPRNARhabdoviridaeInsertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay1 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2348Vesicular stomatitis viruswild typeRNARhabdoviridaeNoneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay0.01 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2362Vesicular stomatitis virusVSV-Delta-M51-GFPRNARhabdoviridaeDeletion of M51 gene and insertion of GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay0.01 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2376Vesicular stomatitis virusVSV-p1-GFPRNARhabdoviridaeInsertion of P geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay0.01 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2390Vesicular stomatitis virusSev-GFPRNARhabdoviridaeVirus expressing GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay0.01 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_2404Vesicular stomatitis virusRSV-GFPRNARhabdoviridaeVirus expressing GFP geneYesNoNoATCCPancreatic ductal adeonocarcinoma cell lineBxPC-380% confluent monolayerNAMTT assay0.01 MOI100% cell survival after 5 daysNoNoNA No responseNANADownregulation of IFN-GammaNA22238308
OV_3404Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.001 MOINo cell killing after 72 hoursNoNoNA No responseNANANANA28607950
OV_3405Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.005 MOINo cell killing after 72 hoursNoNoNA No responseNANANANA28607950
OV_3406Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.01 MOINo cell killing after 72 hoursNoNoNA No responseNANANANA28607950
OV_3407Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.05 MOI35% cell killing after 72 hoursNoNoNA No responseNANANANA28607950
OV_3408Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPYesNoNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.1 MOI30% cell killing after 72 hoursNoNoNA No responseNANANANA28607950
OV_3424Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with gemcitabine (2 × 10⁻² micromolar) after 1 hourNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.01 MOI75% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3425Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with gemcitabine (2 × 10⁻² micromolar) after 24 hourNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.01 MOI75% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3432Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (1 × 10⁻² micromolar) after 1 hourNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.01 MOI25% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3433Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (1 × 10⁻² micromolar) after 24 hourNoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.01 MOI50% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3440Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (5 nM)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.01 MOI70% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3441Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (5 nM)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.03 MOI60% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3442Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (5 nM)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNASRB assay0.05 MOI52% of the tumor cell mass remain after 72 hoursNoNoNA No responseNANANANA28607950
OV_3443Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (5 nM)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNACTB assay0.01 MOI50% cell viability after 72 hoursNoNoNA No responseNANANANA28607950
OV_3444Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (5 nM)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNACTB assay0.03 MOI40% cell viability after 72 hoursNoNoNA No responseNANANANA28607950
OV_3445Vaccinia virusGLV-1h68DNAPoxviridaeInsertion of three gene beta-glucouronidase, galactosidase and GFPNoVirus in combination with nab-palcitaxel (2.5 nM)and gemcitabine (5 nM)NoATCCHuman pancreatic adenocarcinoma cell lineBxPC-34.0E+4 cells per wellNACTB assay0.05 MOI30% cell viability after 72 hoursNoNoNA No responseNANANANA28607950
OV_3538AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI90% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3539AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay5 MOI80% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3540AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay10 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3541AdenovirusAdenovirus ZD55DNAAdenoviridaeDeletion in E1B55 viral proteinYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay20 MOI58% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3542AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3543AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay5 MOI50% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3544AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay10 MOI40% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3545AdenovirusAdenovirus GD55DNAAdenoviridaeGOLPH2 regulated aoncolytic adenovirusYesNoNoShanghai cell collectionHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay20 MOI30% cell viabilityNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANA28880012
OV_3619Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI60% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3620Measles viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI20% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3633Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI60% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3634Mumps viruswild typeRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI10% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3647Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI30% cell viability after day 3NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3648Measles and mumps viruswild typeRNAParamyxoviridaeNoneNoMeasles virus in combination with mumps virusNoATCCHuman prostate cancer cell linePC-35000 cells per wellNAMTT assay1 MOI12% cell viability after day 6NoNoNA No responseNAVirus in combination with induce apiptosis in cancer cellNANA29485292
OV_3723Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3NANAAbsorbance measurements0.1 MOI15% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3724Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3M-LucNANAAbsorbance measurements0.1 MOI50% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3730Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3NANAAbsorbance measurements10 MOI15% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3731Vesicular stomatitis virusVSV-GPRNARhabdoviridaevirus expressing GP proteinYesNoNoATCCHuman prostate cancer cell linePC-3M-LucNANAAbsorbance measurements10 MOI18% cell viableNoNoNA No responseVirus induce apoptosis in cancer cellNANANA29696636
OV_3753Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.0001 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3754Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.001 MOI100% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3755Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.01 MOI98% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3756Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay1 MOI20% cell survival after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3757Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay2 MOI100% cell killing after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3758Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKYesNoNoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay3 MOI100% cell killing after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3767Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (1 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.1 MOI60% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3768Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (1 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.5 MOI50% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3769Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (5 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.1 MOI40% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_3770Vaccinia virusvv-smacDNAPoxviridaeInsertion of smac and gpt gene in TKNoVirus in combination with gemcitabine (5 micromolar)NoType culture collection of chinaHuman pancreatic cancer cell lineBxPC-35.0E+3 cells per wellNAMTT assay0.5 MOI30% cell viability after 48 hoursNoNoNA No responseNAVirus induce apoptosis in cancer cellNANA30365143
OV_4126AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (0.01 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100 vp/cell80% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4127AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000 vp/cell50% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4128AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (10 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay10000 vp/cell20% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4129AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (100 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100000 vp/cell100% cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4130AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterNoVirus in combination with drug Gemcitabine (1000 ng/ml)NoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000000 vp/cell100% cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4131AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100 vp/cell100% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4132AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000 vp/cell85% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4133AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay10000 vp/cell35% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4134AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay100000 vp/cell20% cell survivalNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4135AdenovirusAduPARE1ADNAAdenoviridaeAddition of E1A gene upstream of uPAR promoterYesNoNoATCCHuman pancreatic cancer cell lineBxPC-33.0E+3 cells per wellNAMTT assay1000000 vp/cell100% cell killingNoNoNA No responseNAVirus induce apoptosis process leads to cancer cell deathNANA26227809
OV_4308AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman prostate adenocarcinomaPC-34000 cells per wellNAMTT assay10 pfu72.7 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4330AlphavirusM1RNATogaviridaeNoneYesNoNoATCCHuman pancreas adenocarcinomaBxPC-34000 cells per wellNAMTT assay10 pfu98.8 % cell viability after 72 hoursNoNoNA No responseNAActivation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosisNANA26373347
OV_4909Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay0.1 MOI100% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4910Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay1 MOI100% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4911Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay10 MOI100% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4912Adenoviruswild typeDNAAdenoviridaeNoneYesNoNoJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay50 MOI100% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4913Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay0.1 MOI100% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4914Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay1 MOI90% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4915Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay10 MOI30% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4916Adenoviruswild typeDNAAdenoviridaeAddition of IL21 gene in virus genomeYesNoVirus expressing IL-21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay50 MOI15% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4917Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay0.1 MOI70% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4918Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay1 MOI40% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4919Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay10 MOI15% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_4920Adenoviruswild typeDNAAdenoviridaeAddition of IL21 and CCL21gene in virus genomeYesNoVirus expressing IL-21 and CCL21 geneJilin University chinaHuman prostate cancer cell linePC-3M1 million cells per wellNAMTT assay50 MOI15% cell viability after 7 daysNoNoNA No responseNANAActivate proloferation of B-cell and Naive T-cellNA27157859
OV_5065Avian orthoreovirusARV-PB1RNAReoviridaeNoneYesNoNoATCCHuman pancreatic cancer cell linePC-31.0E+3 cells per wellNACrystal violet staining10 MOI80% cell viability after 96 hoursNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28441762
OV_5072AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay1 MOI100% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5073AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay2 MOI98% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5074AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay4 MOI70% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5075AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay8 MOI60% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5076AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesNoVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay16 MOI55% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5077AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 5ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay1 MOI55% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5078AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 10ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay2 MOI45% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5079AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 20ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay4 MOI30% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5080AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 40ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay8 MOI20% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5081AdenovirusZD-55-TRAIl-IETD-smacDNAAdenoviridaeAddition of TRAIL and smac gene via IETD linkerYesVirus in combination with SNS032 80ng/mlVirus expressing TRAIL geneShanghai cell collectionHuman pancreatic cancer cell lineBxPC-31.0E+4 cells per wellNAMTT assay16 MOI10% cell viabilityNoNoNA No responseNAInduction of apoptosisInduction of Interferon related gene expressionNA28440486
OV_5559Sindbis virusAR339RNATogaviridaeNoneYesNoNoNAHuman pancreatic cell lineBxPC-31.0E+5 cells per wellNANA1 MOISignificant death of cancer cell line after 72 hoursNoNoNA No responseNAInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5564Reoviruswild typeRNAReoviridaeNoneYesNoNoNAHuman pancreatic cell lineBxPC-31.0E+5 cells per wellNANA1 MOISignificant death of cancer cell line after 72 hoursNoNoNA No responseNAInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5569Sindbis virusAR339RNATogaviridaeNoneNoSindbis virus in combination with ReovirusNoNAHuman pancreatic cell lineBxPC-31.0E+5 cells per wellNANA1 MOIEnhancer cytolytic effect in combination after 72 hoursNoNoNA No responseNAInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5575Sindbis virusAR339RNATogaviridaeNoneYesNoNoNAHuman pancreatic cell lineBxPC-3NANANANANANude mice xenografted subcutaneously for BxPC31.0E+6 pfuNA Tumor volume reduced to below 2.0 cm after 10 weeksIntratumoralInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5576Reoviruswild typeRNAReoviridaeNoneYesNoNoNAHuman pancreatic cell lineBxPC-3NANANANANANude mice xenografted subcutaneously for BxPC31.0E+6 pfuNA Tumor volume reduced to below 3.0 cm after 10 weeksIntratumoralInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5577Sindbis virusAR339RNATogaviridaeNoneNoSindbis virus in combination with ReovirusNoNAHuman pancreatic cell lineBxPC-3NANANANANANude mice xenografted subcutaneously for BxPC31.0E+6 pfuNA Complete reduction in tumor volume after 10 weeksIntratumoralInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5578Sindbis virusAR339RNATogaviridaeNoneYesNoNoNAHuman pancreatic cell lineBxPC-3NANANANANANude mice xenografted subcutaneously for MIAPaCa-21.0E+6 pfuNA Tumor volume reduced to below 5.0 cm after 12 weeksIntratumoralInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5579Reoviruswild typeRNAReoviridaeNoneYesNoNoNAHuman pancreatic cell lineBxPC-3NANANANANANude mice xenografted subcutaneously for MIAPaCa-21.0E+6 pfuNA Tumor volume reduced to below 4.0 cm after 12 weeksIntratumoralInduction of apoptosis by virus infectionNANAUS7270812B2
OV_5623Newcastle disease virusNDV-MK107RNAParamyxoviridaeNoneYesNoNoNAHuman prostate cancer cell linePC-380% confluencyNAMTT assay3×10³ pfu50% of cancer cell death occursNoNoNA No responseNAInduction of apoptosis by virus infectionInduction of IFN-Gamma productionNAUS7470426
OV_5843Newcastle disease virusNDV-PPMK107RNAParamyxoviridaeNoneYesNoNoNAHuman prostae carcinoma cell linePC-380% confluencyNANA3.1 ×10³ pfu50% cancer cell deathNoNoNA No responseNANANANAUS8105578
OV_5888Respiratory synctial virusMutantRNAParamyxoviridaeNoneYesNoNoATCCHuman prostate cancer cell linePC-3NANAMTT assay2 MOI20% cell survived after treatmentNoNoNA No responseNAInduction of apoptosis as measured by TUNEL assayNANAUS9241998
OV_5893AdenovirusCGTG-602DNAAdenoviridaeVirus E1A promoter is replaced by human E2F1 promoterYesNoNoATCCHuman prostate cancer cell linePC-3-MM2NANAMTT assay1 ×10⁴ pfuAll cell death occurs after 100 daysNoNoNA No responseNANANANAUS9410129